Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Atlas Arteria ( (AU:ALX) ) has shared an announcement.
Atlas Arteria reported a marginal 0.1% rise in proportionate toll revenue for the first quarter of 2026 versus a year earlier, or 1.6% excluding foreign exchange effects. The group noted mixed traffic trends across its network, with heavy vehicle volumes generally stronger than light vehicles and limited impact so far from global macroeconomic and fuel price pressures.
In France, APRR traffic fell 0.9% but toll revenue grew 1.1% helped by CPI-linked toll hikes, while the A79 and ADELAC posted solid gains in both traffic and revenue. In contrast, Germany’s Warnow Tunnel suffered sharp traffic and revenue declines due to severe winter weather and tough comparatives.
In the United States, Chicago Skyway achieved higher toll revenue on modest traffic growth and price increases, though heavy vehicle volumes declined amid softer freight flows. The Dulles Greenway continued to outperform with 7.6% traffic growth, as congestion on competing routes bolstered its travel time advantage despite winter weather disruptions.
The most recent analyst rating on (AU:ALX) stock is a Hold with a A$4.96 price target. To see the full list of analyst forecasts on Atlas Arteria stock, see the AU:ALX Stock Forecast page.
More about Atlas Arteria
Atlas Arteria is a listed toll road operator with a portfolio of motorway and tunnel concessions in Europe and North America. Its assets include the APRR Group and A79 in France, ADELAC near Geneva, the Warnow Tunnel in Germany, Chicago Skyway in the United States and the Dulles Greenway in Virginia, with revenues largely under CPI-linked tolling regimes.
YTD Price Performance: -8.45%
Average Trading Volume: 2,426,764
Technical Sentiment Signal: Sell
Current Market Cap: A$6.2B
Learn more about ALX stock on TipRanks’ Stock Analysis page.

